DermaSensor Inc.
Developer of a handheld point-of-care optical spectroscopy device and associated machine-learning algorithm for non-invasive assessment of suspicious skin lesions. The company combines elastic scattering spectroscopy (ESS) hardware, a locked FDA-cleared AI algorithm, clinical study evidence, cloud device management, and customer support to enable rapid objective risk outputs to inform referral decisions in primary care and other outpatient settings.
Industries
N/A
Products
Handheld optical spectroscopy skin lesion assessment device
A wireless, ergonomically designed handheld probe that records multiple spectral measurements from skin lesions and produces an instant objective malignancy risk output using an embedded algorithm.
Handheld optical spectroscopy skin lesion assessment device
A wireless, ergonomically designed handheld probe that records multiple spectral measurements from skin lesions and produces an instant objective malignancy risk output using an embedded algorithm.
Services
Reimbursement guidance and documentation support
Consultant-guided support for payer documentation, coding guidance and claims submission processes through a reimbursement partner.
Clinical training and onboarding
Provision of IFU, quick-reference guides, e-learning courses and on-demand customer support to train clinical staff on device operation.
Live product demonstrations
Personalized on-site or virtual demos to show device operation, clinical workflow integration, and performance characteristics.
Reimbursement guidance and documentation support
Consultant-guided support for payer documentation, coding guidance and claims submission processes through a reimbursement partner.
Clinical training and onboarding
Provision of IFU, quick-reference guides, e-learning courses and on-demand customer support to train clinical staff on device operation.
Live product demonstrations
Personalized on-site or virtual demos to show device operation, clinical workflow integration, and performance characteristics.
Expertise Areas
- Optical spectroscopy for tissue assessment
- Machine learning for clinical diagnostics
- Prospective clinical study conduct and clinical utility evaluation
- Regulatory strategy for medical devices (FDA clearance and Breakthrough Device pathway)
Key Technologies
- Elastic scattering spectroscopy (ESS)
- Supervised machine learning for diagnostic scoring
- Handheld optical probe hardware
- Spectral data acquisition and signal processing